Evaluation of the Oral Iron Chelator 1,2-Dimethyl-3-hydroxypyrid-4-one (L1) in Iron-Loaded Patients
- 1 December 1990
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 612 (1) , 369-377
- https://doi.org/10.1111/j.1749-6632.1990.tb24324.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- SAFETY OF ORAL IRON CHELATOR L1The Lancet, 1989
- ANIMAL TOXICOLOGY OF IRON CHELATOR L1The Lancet, 1989
- 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOADThe Lancet, 1987
- Simple synthesis of the potent iron chelators 1-alkyl-3-hydroxy-2-methylpyrid-4-onesInorganica Chimica Acta, 1987
- The relationship between lipophilicity of hydroxypyrid-4-one iron chelators and cellular iron mobilization, using an hepatocyte culture modelBiochemical Society Transactions, 1986
- Evaluation in vivo of hydroxypyrid-4-one iron chelators intended for the treatment of iron overload by the oral routeBiochemical Society Transactions, 1986
- Growth and sexual maturation in thalassemia majorThe Journal of Pediatrics, 1985
- DESFERRIOXAMINE TO IMPROVE CARDIAC FUNCTION IN IRON-OVERLOADED PATIENTS WITH THALASSAEMIA MAJORThe Lancet, 1984
- IMPROVEMENT IN IRON STATUS AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1979
- Minimum sample preparation for the determination of ten elements in pig faeces and feeds by atomic-absorption spectrophotometry and a spectrophotometric procedure for total phosphorusThe Analyst, 1979